Opko Healthincis A Diversified Healthcare Company Based In Miamifloridafounded In 2007It Is Publicly Traded On Nasdaq And The Tel Aviv Stock Exchange Under The Symbolopkand Is Part Of The Russell 2000 Indexphillip Frost Serves As The Chairman And Ceo The Company Operates In Two Main Segmentsdiagnostics And Pharmaceuticalsin The Diagnostics Segmentopko Health Offers A Variety Of Testing Services Through Bioreference Laboratoriesincluding Molecular Diagnostics And Genetic Testingthe 4Kscore Test Is A Notable Product For Prostate Cancer Detectionin The Pharmaceuticals Segmentopko Health Provides Several Medicationssuch As Rayaldee For Chronic Kidney Diseasevarubi For Chemotherapy Induced Nauseaand Somatrogona Human Growth Hormone Injectionthe Company Also Develops Longer Acting Versions Of Therapeutic Proteins And Markets A Range Of Pharmaceutical And Nutraceutical Products With Operations In Over 30 Countriesopko Health Serves Healthcare Providersincluding Physician Offices And Hospitalsin 2022The Company Expanded Its Capabilities By Acquiring Modexa Biotechnology Firm Specializing In Immunotherapy Technology
No conferences found for this company.
| Company Name | Opko Ecuador Sas |
| Country |
Ecuador
|
| Address | N/A |
| Telephone | N/A |
| N/A |
